Abstract:OBJECTIVE:To investigate the clinical characteristics of cytomegalovirus retinitis (CMVR) in acquired immunodeficiency syndrome (AIDS) patients.METHODS:Retrospective case-series study. The clinical and laboratory data of 80 AIDS patients (118 eyes) with findings of CMVR were collected from Shanghai Public Health Clinical Center from December 2006 to December 2011. The relationship between CMVR and cellular immunity, the high risk factor, clinical characteristics, treatment and prognosis of CMVR were analyzed in this study. χ(2) test was used to check the incidence of CMVR in different CD4(+) T lymphocyte count groups.RESULTS:There was 80 AIDS patients (118 eyes) totally, 71 males and 9 females. Their age was from 18 to 60 years old, which mean value was (38 ± 10) years old. The incidence in the group of CD4(+) T lymphocyte count over 100 cells/µl was lower than the two groups of CD4(+) T lymphocyte count less than 100 cells/µl (χ(2) = 15.567, 32.469; P = 0.00,0.00). CD4(+) T lymphocyte count was always ranged from 0 to 141 cells/µl in CMVR patients. It was less than 50 cells/µl in 81.3% cases. In 10.0% AIDS patients, CMVR was the first manifestation. In 25% AIDS patients(26 eyes), lesions in retina was found by routine eye examination. In 54.2% patients, the best corrected visual acuity was less than 0.3. Retinal necrosis was involvement near the posterior pole in 62.5% CMVR patients. The visual acuity of 51 eyes was improved after treatment within 94.1% cases which were treated within 3 months. However, BCVA of 35 eyes decreased or with less change within 42.9% cases which were treated after symptoms appeared 3 months. The anti-CMV treatment included induction and maintenance of ganciclovir or foscarnet stopped when the CD4(+)T lymphocyte count was more than 150 cells/µl in 3 continuous months. 86.9% eyes were cured clinically. Retinal detachment, immune reconstitution uveitis and complicated cataract was found in 13.1%, 12.1% and 20.5% cases respectively. Optic atrophy occurred in 6 eyes. The visual acuity of 28.9% eyes was 0.05 or less, 71.3% of that caused by retinal detachment, cataract and optic atrophy.CONCLUSIONS:CD4(+) T lymphocyte count reduction is the risk factor for CMVR. HAART and anti-CMV therapy will cure the CMVR clinically.Routine eye examinations should be performed in all AIDS patients to get early diagnosis of CMVR or other opportunistic infections to avoid vision loss, especially in those CD4(+) T lymphocyte count lower than 100 cells/µl.

Treatment of retinal detachments in patients with the acquired immune deficiency syndrome

Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis

Treating cytomegalovirus retinitis-related retinal detachment by combining silicone oil tamponade and ganciclovir implant

Non-Buckled Vitrectomy for Retinal Detachment with Inferior Breaks and Proliferative Vitreoretinophathy

Clinical Characteristics and Management Outcomes of Rhegmatogenous Retinal Detachments Due to Retinal Dialysis

Incidence and management of cataract after retinal detachment repair with silicone oil in immune compromised patients with cytomegalovirus retinitis

Encircling band, laser retinopexy and lens removal as standard procedure in complicated retinal detachment shows a good clinical outcome

Clinical Characteristic and Treatment of Cytomegalovirus Retinitis in 80 Patients with Acquired Immunodeficiency Syndrome

[Evaluation of Treatment for Retinal Detachment in Juveniles].

LONG-TERM RESULTS OF VITRECTOMY WITHOUT ENDOTAMPONADE IN PROLIFERATIVE DIABETIC RETINOPATHY WITH TRACTIONAL RETINAL DETACHMENT

Treatment for acute retinal necrosis

Management of Non-Inferior Rhegmatognous Retinal Detachment with Vitrectomy and Air Tamponade

Antiviral therapy for cytomegalovirus retinitis: A systematic review and meta-analysis

Outcomes in Retinal Detachment Repair and Laser Prophylaxis for Syndromes with Optically Empty Vitreous

Cytomegalovirus retinitis associated with acquired immunodeficiency syndrome

Treatment of the сomplications of long-term silicone oil tamponade in a patient with retinopathy of prematurity and recurrent retinal detachment

Vitrectomy versus scleral buckle for retinal detachment without posterior vitreous detachment

SURGICAL OUTCOMES OF RETINAL DETACHMENT ASSOCIATED WITH PROLIFERATIVE SICKLE CELL RETINOPATHY

Laser photocoagulation after the scleral buckling for retinal detachment

An Analysis of the Efficacy of Vitreous Surgery Combined with Silicon Oil Tamponade for Retinal Detachment Patients Associated with Choroidal Detachment

Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and Treatment